(Adnkronos) - Grande partecipazione alla VII edizione del Theras Day, l’appuntamento che riunisce i diabetologi nazionali e internazionali. Tra le novità tecnologiche presentate alla due giorni organizzata a Milano da Theras, tra i leader nella ricerca e nella commercializzazione di tecnologie d'avanguardia per il trattamento di patologie come diabete e dolore cronico, un focus particolare è stato dedicato alla disponibilità in Italia di Omnipod® 5, l’innovativo sistema di erogazione automatica di insulina senza catetere, particolarmente utile per migliorare la qualità di vita delle persone con diabete, compresi bambini e adolescenti.
Category
🗞
NewsTranscript
00:00Great participation at Terrace Day, the meeting that brings together the most prestigious national and international diabetologists.
00:12The 7th edition wanted to celebrate the connection between innovation and transformation.
00:17During the two days organized in Milan by Terrace, among the leaders in research and commercialization of cutting-edge technologies
00:24for the treatment of chronic pathologies such as diabetes and chronic pain,
00:28the latest news on digital therapies for chronic diseases have been highlighted.
00:34A particular focus has been dedicated to the availability in Italy of Omnipod 5,
00:40the automatic supply system of insulin without catheters,
00:44integrated with sensors for the monitoring of compatible glucose.
00:50The advantages are 360 degrees.
00:54The first is a clinical advantage.
00:57The glycemic control of people with diabetes improves and improves significantly.
01:02Improving glycemic control means preventing the development of complications.
01:07The second advantage is related to the improvement of the quality of life of people with diabetes,
01:13which is an equally important aspect.
01:15The third advantage is the ease of use of the system,
01:19which allows to use it in a very practical and simple way.
01:24It is therefore a system that is able to impact in terms of innovation and opportunity in the lives
01:31not only of people with diabetes, but also of us professionals
01:35who propose the best treatment opportunities for this disease.
01:41The innovative technology is suitable for people with type 1 diabetes of the same age or older than 2 years.
01:47It is therefore an advantageous tool also in the pediatric field for patients and their caregivers.
01:53I believe that among the values of this tool there is also that of being able to use it
01:58in children who have special needs and teenagers who refuse any type of therapy.
02:06It is able to guarantee, on the one hand, a much higher metabolic control
02:11compared to traditional therapies and, on the other hand, a much improved quality of life.